Position in DNLI
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$423,787
+$148,479 QoQ
Shares Held
16,477
+14.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#157
of 290 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INTRUST BANK NA holds $7,617,692 across 12 Biotechnology names. DNLI ranks #8 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,808 | $1,891,547 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
4,779 | $1,169,755 | |
| 3 | ARGX |
Argenx SE
|
1,091 | $1,012,196 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
31,048 | $540,235 | |
| 5 | CYTK |
Cytokinetics Inc
|
6,334 | $539,592 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
6,518 | $510,162 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
903 | $484,865 | |
| 8 | DNLI |
Denali Therapeutics Inc.
This page
|
16,477 | $423,787 |
All Filings in DNLI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $423,787 | 16,477 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $275,308 | 14,339 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $184,317 | 11,164 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $153,549 | 10,575 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||